Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lipid abnormalities in HIV-infected patients are not correlated with lopinavir plasma concentrations.
Torti C, Quiros-Roldan E, Regazzi-Bonora M, De Luca A, Lo Caputo S, Di Giambenedetto S, Patroni A, Villani P, Micheli V, Carosi G; Resistance and Dosage Adapted Regimens Study Group of the MASTER Cohort. Torti C, et al. Among authors: de luca a. J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):324-6. doi: 10.1097/00126334-200403010-00017. J Acquir Immune Defic Syndr. 2004. PMID: 15076251 Clinical Trial. No abstract available.
Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapy.
Gillini LA, Cingolani A, Murri R, De Luca A, Di Giambenedetto S, Wu A, Cauda R, Chaisson RE. Gillini LA, et al. Among authors: de luca a. J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):546-7. doi: 10.1097/00126334-200204150-00018. J Acquir Immune Defic Syndr. 2002. PMID: 11981374 No abstract available.
Interpretation systems for genotypic drug resistance of HIV-1.
De Luca A, Antinori A, Di Giambenedetto S, Cingolani A, Colafigli M, Perno CF, Cauda R. De Luca A, et al. Scand J Infect Dis Suppl. 2003;106:29-34. doi: 10.1080/03008870310009623. Scand J Infect Dis Suppl. 2003. PMID: 15000579 Review.
The influence of hepatitis C virus coinfection on the risk of lipid abnormalities in a cohort of HIV-1-infected patients after initiation of highly active antiretroviral therapy.
Di Giambenedetto S, Baldini F, Cingolani A, Tamburrini E, Cauda R, De Luca A. Di Giambenedetto S, et al. Among authors: de luca a. J Acquir Immune Defic Syndr. 2004 May 1;36(1):641-2. doi: 10.1097/00126334-200405010-00015. J Acquir Immune Defic Syndr. 2004. PMID: 15097310 No abstract available.
Triple-nucleoside regimens versus efavirenz.
De Luca A, Di Giambenedetto S. De Luca A, et al. N Engl J Med. 2004 Aug 12;351(7):717-9; author reply 717-9. doi: 10.1056/NEJM200408123510720. N Engl J Med. 2004. PMID: 15306677 No abstract available.
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study.
Torti C, Quiros-Roldan E, Regazzi M, De Luca A, Mazzotta F, Antinori A, Ladisa N, Micheli V, Orani A, Patroni A, Villani P, Lo Caputo S, Moretti F, Di Giambenedetto S, Castelnuovo F, Maggi P, Tinelli C, Carosi G; RADAR-MASTER Study Group. Torti C, et al. Among authors: de luca a. Clin Infect Dis. 2005 Jun 15;40(12):1828-36. doi: 10.1086/429917. Epub 2005 May 12. Clin Infect Dis. 2005. PMID: 15909273 Clinical Trial.
Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy.
Marzocchetti A, Di Giambenedetto S, Cingolani A, Ammassari A, Cauda R, De Luca A. Marzocchetti A, et al. Among authors: de luca a. J Clin Microbiol. 2005 Aug;43(8):4175-7. doi: 10.1128/JCM.43.8.4175-4177.2005. J Clin Microbiol. 2005. PMID: 16081969 Free PMC article.
2,257 results